The influence of liver metastases on the pharmacokinetics of doxorubicin---a population-based pharmacokinetic project of the CESAR-APOH

Int J Clin Pharmacol Ther. 2003 Dec;41(12):598-9. doi: 10.5414/cpp41598.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / metabolism
  • Antibiotics, Antineoplastic / pharmacokinetics*
  • Aspartate Aminotransferases / pharmacology
  • Dose-Response Relationship, Drug
  • Doxorubicin / adverse effects
  • Doxorubicin / metabolism
  • Doxorubicin / pharmacokinetics*
  • Female
  • Humans
  • Liver Neoplasms / complications*
  • Liver Neoplasms / secondary*
  • Male
  • Middle Aged

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin
  • Aspartate Aminotransferases